S unscreen industry stakeholders fac- ing the potential loss of UV flters under FDA’s OTC drug review could have much to gain from the antibacte- rial soap sector, which is about halfway into a fve-year work plan to keep prior- ity germ-killing ingredients available on an OTC basis.
展开▼